Cargando…
Evaluation of zoledronate for the treatment of canine stage III osteosarcoma: A phase II study
BACKGROUND: Greater than 90% of dogs with appendicular osteosarcoma will develop pulmonary metastasis despite the standard of care. Available treatments have limited efficacy for stage III disease. Zoledronate, a bisphosphonate, induces apoptosis of canine osteosarcoma cells and appears to modulate...
Autores principales: | Smith, Ashley A., Lindley, Stephanie E.S., Almond, Greg T., Bergman, Noelle S., Matz, Brad M., Smith, Annette N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857128/ https://www.ncbi.nlm.nih.gov/pubmed/36398717 http://dx.doi.org/10.1002/vms3.1000 |
Ejemplares similares
-
Update on canine anorchia: A review
por: Cicirelli, Vincenzo, et al.
Publicado: (2023) -
Metabolism of ropinirole is mediated by several canine CYP enzymes
por: Tervahauta, Tuomas, et al.
Publicado: (2023) -
Prospective evaluation of canine partial limb amputation with socket prostheses
por: Wendland, Theresa M., et al.
Publicado: (2023) -
Canine mast cell tumours part I: Clinical and survival outcomes
por: Tamlin, Vanessa S., et al.
Publicado: (2022) -
Diverse genome‐wide DNA methylation alterations in canine hepatocellular tumours
por: Asari, Yu, et al.
Publicado: (2023)